ABOUT DIA
For more than 50 years, DIA (the Drug Information Association), a non-profit association, has served as a global forum for all those involved in healthcare product development and lifecycle management to exchange knowledge and collaborate in a neutral setting. DIA is an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation. DIA fosters innovation to improve health and well-being worldwide by: Providing invaluable forums to exchange vital information and discuss current issues related to healthcare products, technologies, and services; Delivering customized learning experiences; Building, maintaining, and facilitating trusted relationships with and among individuals and organizations that drive and share DIA values and mandates; and offering a multidisciplinary neutral environment, respected globally for integrity and relevancy. DIA is your essential partner in catalyzing knowledge creation and sharing to accelerate healthcare product development.
CONTACT INFORMATION
DIA
800 Enterprise Road, Suite 200
Horsham, PA 19044-3595
UNITED STATES
Phone: 215.442.6100
Fax: 215.442.6199
Contact: Michelle Rovner
FEATURED ARTICLES
- Bringing Clinical Research To The Patient Using Patient-Centric Tech
- Why In The World Should You Come to San Diego?
- Solving The Puzzle Of Real-World Data/Evidence
- How Diversity, Innovation, And AI Are Accelerating Health
- Solving The Rubik’s Cube Part 3: Maintaining Human Touch
- Solving The Rubik’s Cube Part 2: Strategic Partnerships
- Solving The Rubik’s Cube Part 1: AI And Data Quality
- Embedding Inclusive Research Principles In Trial Design, Execution
- Regulatory Pathways Supporting Accelerated Drug Approval
- Considerations For Using RWD/RWE In Oncology Drug Approvals
- 5 Building Blocks To Achieving Diversity, Equity, And Inclusion
- Risk-Mitigation Recommendations When Using Technology
- Pitfalls And Possibilities: EHRs To RWD Via EDC
- Advancing Use Of Patient Evidence In Decision-Making
- RWD/RWE In 2023: Regulatory Policy World Tour
- Optimizing Clinical Trials Through Ethical Research
- Data Analytics Could Enable Trial Diversity & Meet New Regulations
- How Generative AI Could Transform Content Development
- Will Technology Solve The Research ‘People Problem’?
- Addressing The Global Clinical Research Workforce